Local NHS welcomes MSK impact assessment
NHS Coastal West Sussex Clinical Commissioning Group (CCG) and Western Sussex Hospitals NHS Foundation Trust have now received the independent review by PwC of the impact a new integrated Musculoskeletal (MSK) service run by Bupa CSH would have on hospital care in our area.
Both organisations welcome the report and the increased understanding it has provided into the likely impacts of the new service following the CCG’s decision to award a new contract earlier this year.
The report, which is considered by all parties to be robust and thorough, has evaluated the financial, clinical and operational impacts and outcomes of the CCG’s decision.
It is clear from the report that if no mitigating actions are put in place, there would be financial and clinical impacts on hospital services.
The joint impact assessment demonstrates that an MSK service run by Bupa CSH would have serious clinical and financial implications that, if not mitigated, would seriously affect the care we are able to provide for patients in our hospitals.
Both organisations remain committed to improving MSK services, ensuring that WSHFT remains sustainable, and that both A&Es at Worthing and St Richard’s Hospitals remain open.
Work is now underway between the CCG and WSHFT, in partnership with Bupa CSH, to address the points raised to make sure hospital services are not adversely affected by the proposed new arrangements for MSK.
Dr Katie Armstrong, Clinical Chief Officer at NHS Coastal West Sussex CCG, said: “The CCG remains committed to improving the way patients with an MSK condition receive their services.
“We know that the staff work hard to deliver good care, but also know that it is delivered in a way that lacks co-ordination.
“Our patients and clinicians told us that services weren’t working well together. Our objective has always been to improve services for patients. This has not changed.
“The impact assessment has given us the opportunity to fully explore the financial and clinical implications of the contract award.
“We are looking forward to working with Western Sussex Hospitals NHS Foundation Trust and Bupa CSH to understand the mitigating actions, and we remain committed to improving MSK services for patients.”
Marianne Griffiths, Chief Executive of Western Sussex Hospitals NHS Foundation Trust, said: “The joint impact assessment demonstrates that an MSK service run by Bupa CSH would have serious clinical and financial implications that, if not mitigated, would seriously affect the care we are able to provide for patients in our hospitals.
“We are now looking at the cost, viability and practicality of the mitigations needed to guarantee that no patients are adversely affected by the new contract proposals.
“It must also be remembered that the staff who run our current MSK service, of which I am very proud, make a hugely important contribution to a wide range of other specialties across our hospitals. In the interests of all our patients, it is vital that they are able to continue to do so.”
The independent impact assessment has evaluated the following, but not exclusively:
- The impact on consultant trauma services across the two trauma units at Worthing and St Richard’s
- The impact on training doctor rotas in trauma and in medicine
- The impact on the quality of training provision for junior doctors and other staff
- The longer term impacts on recruitment at WSHFT
- The impact on medical imaging
- The impact that the movement of non MSK physio may have on non MSK acute services
- The impact on under 18s MSK service provision
- The impacts need to be reviewed over the life of the MSK contract
A summary of the impact assessment is available to read or download at the foot of this page.